Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

I said in msg 85375 - "Since my joining this b

Message Board Public Reply | Private Reply | Keep | Replies (7)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155004
(Total Views: 613)
Posted On: 04/15/2021 12:52:50 PM
Posted By: Cassandra X
Re: TechGuru #86658
I said in msg 85375 -

"Since my joining this board I have been saying that the FDA would not be in a hurry to give approval to Cytodyn if they can't demonstrate a proven ability to deliver the drug. That is one of the reasons they like working with BP. CDER is very big on all supply issues.

Perhaps supply concerns were behind the FDA's desire to limit the dosage in the CD12 trials to 2 doses! Now with 4 doses looking like the future dosage protocol and the LH trials and foreign buyers, we're going to need a lot more Leronlimab, so much more!"

Because Cytodyn is small, pre-revenue and does not have a PROVEN ABILITY TO DELIVER large quantities of Leronlimab, the FDA is reluctant to give Cytodyn any kind of approval, EUA or otherwise except eIND.

They, no doubt, would like for Cytodyn to work with them ON THEIR TERMS or sell out to BP or they hope some BP outfit will come up with another drug that can do what Leronlimab does. Any of these things would deal with the supply problem and that's what they want!

Cytodyn's conumdrum is they have to make sales somehow large enough to buy more Leronlimab!

So with the pitiful amount of Leronlimab Cytodyn has on hand, especially if it is going to take more doses to treat critical patients, EVERY TIME we hear what sounds like GOOD NEWS like 200K to the Philippines or 500K to Brazil or use of Leronlimab for another indication or more doses per treatment, anything, the FDA probably looks COLDLY on Cytodyn!

If Cytodyn could supply the needed quantities to treat 100 million people like BP can do with the vaccines, the FDA would approve them immediately! If they can't, they get the treatment they are getting now and not because of corruption.

Cytodyn has chosen the door-to-door salesman route - knock on a lot of doors until someone buys. This strategy will probably work. But in the mean time, Leronlimab is getting little chance to save lives!





(5)
(2)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us